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1. Introduction 
1.1 History 
Historically, several terms have been used to depict pseudotumor cerebri (PTC). In the late 
1890's, Quincke (1893, 1897) was the first to describe and name this syndrome - "meningitis 
serosa" - patients suffering from headache, impaired visual acuity and papilledema. He 
related the symptoms to a state of elevated intracranial pressure and presumed it was 
caused by increased secretion of CSF by the autonomic nervous system. In 1904, Nonne 
(1904) termed this syndrome "pseudotumor cerebri" as the symptoms resembled a suspected 
intracranial mass. Foley (1955) renamed the condition "benign intracranial hypertension". 
However, in the late 1980's, Corbett et al (1982) altered the name to idiopathic intracranial 
hypertension, since the syndrome was not benign as once thought. In some cases, up to 25% 
of patients may lose their vision if appropriate treatment measures are not taken. At present, 
idiopathic intracranial hypertension is the accepted designation. 
1.2 Demographics and epidemiology 
Pseudotumor cerebri (PTC), also known as idiopathic intracranial hypertension (IIH) is a 
disorder of unknown etiology, predominantly affecting obese women of childbearing age 
(Ahlskog & O'Neill, 1982). In the general population, the annual incidence of PTC is 
estimated between 1-2 per 100,000 (Friedman & Jacobson, 2002, 2009). The incidence has 
been reported to have risen to 3.5 per 100,000 in women aged 20 - 44 years and may reach as 
high as 19 cases per 100,000 in women who are >20% over the ideal body weight (Durcan, 
1988; Kesler et al 2001; Radhakrishnan et al., 1993, 1994). 
PTC is uncommon in men, with female to male ratios reported approximately 4.3:1 to 8:1 
(Binder et al, 2004; Durcan, 1988). The association between obesity and PTC is well 
established, >90% of women and >60% of men who suffer from this disorder are obese 
(Friedman et al., 2002; Radhakrishnan et al, 1994). The syndrome is relatively rare in the 
pediatric population. In the pre-pubertal population, it seems that obesity is not a risk factor. 
There is an equal distribution between boys and girls with an estimated incidence of 
approximately 1 case per 100,000.  
1.3 Presenting signs and symptoms  
Headaches, the most common presenting symptom in all age groups, occur in >90% of 
patients (Binder et al., 2004; Lessell, 1992). A PTC-associated headache has no specific 
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characteristics, but is usually more severe and different than previously described 
headaches. In PTC, the headache is most commonly bifrontal or generalized, usually 
occurring daily, but may also occur intermittently, worsening in the morning. When 
cerebral venous pressure is increased by the Valsalva maneuver, the headaches are often 
exacerbated and accompanied by neck pain. 
Transient visual obscurations (TVO), the second most common symptom is more frequently 
reported in adult patients than in pediatric PTC patients, 72% vs. 2-53% respectively 
(Lessell, 1992). TVO may be unilateral or bilateral, usually lasting less than a minute and 
often precipitated by a change in posture. TVO indicate the presence of optic disc edema 
resulting in transient ischemia to the optic nerve head. Over half (60%) of PTC patients may 
experience pulsatile tinnitus as the initial complaint. Pulsatile tinnitus is thought to result 
from a turbulence created by higher to lower venous pressure around the jugular bulb 
(Binder et al., 2004). 
In patients with PTC, focal neurological deficits are extremely uncommon. An alternative 
diagnosis should be considered when these deficits occur. Nevertheless, isolated 6th cranial 
nerve paresis, thought to be attributed to nerve traction from increased intracranial pressure 
has been observed in approximately 20% of adult cases (Binder et al., 2004). However, in 
children, the incidence was found to be as high as 50% (Cinciripini et al 1999; Lessell, 1992; 
Rangwala & Liu, 2007). Paresis of the 3rd, 4th, 7th or 12th nerve is extremely rare, occurring 
mostly in the pediatric population. Young children with PTC may present with irritability 
rather than headaches (Lessell, 1992), and may consequently develop signs of a posterior  
  
 
Fig. 1. Papilledema in a 26 year old PTC female patient. 
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fossa lesion, including ataxia, facial palsy, nuchal rigidity, malaise, torticollis (Lessell, 1992; 
Rangwala & Liu, 2007). 
Papilledema is the diagnostic hallmark of PTC and is present in almost all patients (Mathew, 
1996) (Figure 1). To note, although, unilateral cases may be encountered in approximately 
10% of cases (Maxner et al., 1997; Wall & White, 1998) and a small number of patients may 
not have papilledema at all (Mathew, 1996; Wang et al., 1998; Winner & Bello, 1996), most 
cases occur either in very young infants with unfused sutures or in patients with anatomical 
variants of the endings of the optic nerve sheath (Hayreh, 1977; Killer et al., 1999). 
Post-papilledema optic atrophy can occurs in untreated or inadequately treated patients 
after variable periods of time, usually over several months; in rare cases of fulminant PTC it 
can appear within weeks of the onset of symptoms. Some patients have persistent chronic 
papilledema without obvious visual deterioration. Visual field testing is the most sensitive 
method for detecting visual dysfunction. The most common abnormalities are an enlarged 
blind spot, generalized constriction and inferior nasal field loss. 
1.4 Diagnosis 
Diagnosis criteria for PTC were reviewed (Binder et al., 2004) (Table 1) and include signs 
and symptoms attributable to increased ICP, elevated CSF pressure with normal CSF 
content and normal neuroimaging studies. Other etiologies of intracranial hypertension 
were excluded. When these criteria are present, neuroimaging is employed to rule out space 
occupying lesions and sinus vein thrombosis. Lumbar puncture is subsequently performed 
to measure CSF opening pressure. Generally, an opening pressure of >250mm of water 
measured in a patient lying in the decubitus position, with outstretched legs and as relaxed 
as possible, is indicative of increased pressure. A pressure value between 201 and 249mm of 
water is inconclusive (Corbett & Mehta, 1983); pressure equal to or <200mm of water is 
considered normal. Often, due to CSF fluctuations, low or inconclusive measurements must 
be re-evaluated, especially if the clinical picture is indicative of increased ICP.  
According to Tibussek et al (2010), a diagnosis of "probable PTC" would be indicated in 
patients, especially children, with clinical manifestations highly suggestive of PTC, but with 
a normal CSF opening pressure, presumably due to diurnal fluctuations. Rarely, in these 
circumstances, is a 24 hour intracranial CSF pressure monitoring, or transducer monitoring 
for 6 to 24 hours needed to confirm the diagnosis (Spence et al., 1980). 
2. Neuroradiological evaluation 
A detailed section in this chapter is devoted to diverse imaging modalities in patients with 
PTC. Imaging plays an important role in excluding intracranial tumors and structural or 
vascular lesions responsible for intracranial hypertension. CT, although adequate in ruling 
out hydrocephalus and most mass lesions, conditions such as sinus vein thrombosis, 
meningeal infiltration, and isodense tumors are undetected by a non-enhanced CT. 
An MRI will detect almost all changes and by incorporating MRI venography will further 
enhance the ability to detect sinus vein thrombosis disguised as PTC (Crassard & Bousser, 
2004). In rare cases, imaging of the spinal cord is essential as it excludes rare cases of spinal 
tumors that cause an increase in intracranial pressure. However, this is typically present 
with high protein levels in the CSF, therefore making it incompatible with the definition of 
PTC (Corbett & Mehta, 1983; Friedman & Jacobson, 2004; Ridsdale & Moseley, 1978). 
Traditionally, slit ventricles were thought to be present in PTC, but a quantitative analysis of 
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ventricular volume noted no differences between patients with PTC and age-matched 
control patients (Jacobson et al., 1990). 
Signs of increased intracranial pressure that may be found on imaging studies include 
empty sella (70%), flattening of posterior sclera (80%), enhancement of the prelaminar optic 
nerve (50%), distention of the perioptic subarachnoid space (45%), vertical tortuosity of the 
orbital optic nerve (40%), and intraocular protrusion of the prelaminar optic nerve (30%) 
(Brodsky & Vaphiades, 1998). 
 
1. Symptoms, if present, represent increased intracranial pressure or papilledema. 
2. Signs represent increased intracranial pressure or papilledema. 
3. Documented elevated intracranial pressure during lumbar puncture measured in the 
lateral decubitus  position  
4. Normal cerebrospinal fluid composition. 
5. No evidence of ventriculomegaly, mass, structural, or vascular lesion on magnetic 
resonance imaging or contrast-enhanced computed tomography and magnetic 
resonance venography or computerized venography for all others 
6. No other cause (including medication) of intracranial hypertension identified. 
Table 1. Clinical criteria for diagnosing idiopathic intracranial hypertension (adapted from 
Binder et al 2004) 
3. Pathogenesis 
At present, the pathogenesis of the syndrome is still unknown, however, some explanation 
must account for elevated intracranial pressure with normal neuroimaging, CSF 
constituents and neurologic examination (Corbett, 2008). Intracranial pressure is maintained 
by cerebral arterial pressure which is cerebral autoregulated, resulting in constant 
intracranial pressure.  
CSF is constantly absorbed into the superior sagittal sinus (SSS) at the pacchionian 
granulation level. This process is carried out by a pressure gradient between the CSF and the 
venous pressure in the SSS. When there is a rise in the venous pressure, the CSF pressure 
rises proportionately in order for the CSF to diffuse into the SSS. 
According to the Montro-Kellie rule (Greitz et al., 1992; Mokori, 2001), the increase in ICP 
may be a result of various factors such as an increase in CSF, brain or blood volume. 
Although many studies have been performed, it is still unclear which factor is responsible 
for the increase in ICP in cases of PTC. 
Different hypotheses have been proposed such as, an increase in cerebral blood volume 
which was originally proposed by Dandy in 1937. Raichle et al. (1978), using positron 
emission tomography (PET) found that almost no change occurred in the cerebral blood 
flow (CBF) in PTC patients, however there were markedly increased cerebral blood or water 
volumes. 
A few years later, Brooks et al (1985) using PET, found no change in cerebral 
hemodynamics. Recently, Levine demonstrated that vascular compression and dilatation 
exist in the PTC patient (Levine, 2000). 
Bateman et al. (2007) found that the total CBF measured by magnetic resonance (MR) flow 
quantification and MR venography in the PTC patient, was 46% more elevated then in the 
control group, which may be secondary to cerebral vascular autoregulation. On the other 
hand, Lorberboym et al. (2001) reported a reduction in perfusion, noted on single photon 
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emission CT scans in PTC patients a clear correlation between disease severity and CBF 
reduction. The proposed mechanisms for CBF changes are an increase of the cerebral 
vascular resistance, impairment of the CBF autoregulation, and a decrease of the tissue 
vascular density as a result of cerebral edema (Bateman, 2004)). 
Bicakci et al (2006) recently studied 16 patients with perfusion and diffusion MRI, finding 6 
patients with a statistically reduced CBF, and 2 with a marked increase. All other patients’ 
cerebral blood volume did not significantly increase or decrease compared with the control 
group. Both vasodilatation and compression occurred in the PTC patient depending on the 
duration of the disease. The authors claimed that a long standing increase in CSF pressure 
might result in a decrease in CBF. On the other hand, an increase in CBF may be a result of a 
failure in autoregulation in the first phases of the disease, as suggested by Bateman's study. 
4. Obstruction of venous outflow 
The absence of ventricular dilatation in an elevated ICP condition is most likely explained 
by the presence of venous hypertension. As the pressure in the SSS rises, so does the CSF 
pressure due to hindered absorption of CSF. Brain parenchimal turgor increases due to an 
impending resorption of venous blood. 
In 1995, King et al’s (1995) series of 9 PTC patients with venous hypertension in the SSS and 
proximal transverse sinuses, cerebral venography and manometry were performed.  The 
authors were able to observe the appearance of the transverse sinuses, ranging from a 
smooth tapered narrowing to a discrete intraluminal filling defect resembling mural 
thrombi. 
The authors also found a significant drop in venous pressure at the level of the lateral third 
of the transverse sinus that was not fully explained by the anatomical finding on 
venography. Furthermore this gradient was eliminated after performing a cervical puncture 
which reduced the CSF pressure.  
Karahalios et al (1996) also described a dural venous outflow obstruction found on cerebral 
venography and manometry in 5 out of 10 patients.   A high pressure gradient was observed 
while those without obstruction had elevated right atrial pressure as well as elevated 
venous sinus pressure. The authors concluded that increased venous pressure was common 
in PTC, secondary to intracranial venous outlet obstruction and without anatomical 
obstruction. 
In the same study, Karahalios proposed other hypotheses, such as obesity related 
cardiomyopathy with subsequent congestive heart failure, sleep apnea, carbon dioxide 
retention and increased intra-abdominal pressure. All these conditions benefited from 
diuretic therapy which reduced CSF production and also reduced the central plasma 
volume and hence venous pressure. 
A recent study by Nodelmann (2009) observed that jugular vein valve insufficiency in 
patients with PTC supports the hypothesis that increased ICP may be a result of a more 
general state of venous hypertension, possibly associated with obesity. 
Several studies focusing on the appearance of outflow obstruction on MRI and MRV (Farb et 
al, 2003; Johnston et al., 2002;) produced inconclusive results due to the wide variations of 
radiological appearances of posterior fossa dural sinuses, which may be confused with a 
normal anatomical variant (Lee & Brazis, 2000).  
Higgins et al (2004) published a study comparing 20 patients with PTC who had undergone 
MRV and a control group of 40 healthy volunteers, strictly selected. Patients with a history 
of headaches or other signs or symptoms related to cranial venous involvement were 
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excluded. All subjects were matched for age and sex. A significant difference was observed 
in the appearance of the lateral sinus between the 2 groups; bilateral lateral sinus flow gaps 
were seen in 13 out of 20 (65%) PTC patients compared to none in the control group. 
A new imaging method proposed by Farb et al. (2003) is auto-triggered elliptic-centric-
ordered three-dimensional gadolinium-enhanced MR venography, which may be superior 
to time of flight MR venography in its flow insensitivity and decreased artifactual signal 
loss. Using this new technique, bilateral sinovenous stenosis was found in 27 out of 29 (93%) 
PTC patients compared to only 4 out of 59 (6.5%) in the control group. The authors 
concluded that the distal transverse sinus is the area of pressure gradient as described in 
King et al's study (1995). 
Farb et al (2003) described two types of dural narrowing a “long smooth tapered 
narrowing”, indicating an extra luminal compressive stenosis, and the “acutely marginated 
apparent intraluminal filling defect”, indicating an enlarged, partially obstructing, 
intraluminal arachnoid granulation. They concluded that in PTC patients,  increased dural 
venous pressure is measurable; however, whether this is a primary cause, a contributory 
factor, or a secondary phenomenon is uncertain. 
Two opposing hypotheses can be made. The first proposes that dural sinus stenosis should 
be considered as the primary cause of PTC (fixed stenosis). Kollar et al. (2001) proposed that 
the transverse sinus is narrowed or obstructed by venous sinus thrombosis, vasculitis, 
congenital stenosis, enlarged arachnoid granulations or even heterotropic brain. 
A recently published paper by De Lucia et al (2006) supports the suggested speculation 
that PTC is a long term sequela of previous sinus vein thrombosis or of an unidentified 
thrombus (Nedelmann et al., 2009; Sussman et al., 1997). In their study, 17 PTC patients 
without radiographic evidence of thrombosis were compared to healthy controls. The 
results showed a significant predominance of hypercoagulability markers, including 
protein C deficiency, increased plasma levels of prothrombin fragment 1 and 2, 
fibrinopeptide A, gene polymorphism for factor V leiden mutation, and high titers of 
cardiolipin antibodies. 
The second hypothesis, in contrast to the fixed stenosis theory, suggests a dynamic one, 
where venous obstruction is the consequence and not the primary cause of intracranial 
hypertension. An increased intracranial pressure due to some unknown cause will result in 
a compression of the vascular compartment and dural sinuses which is in agreement with 
the Monroe-Kellie doctrine (Corbett, 2004). It is presumed that the predisposition to this 
phenomenon is due to the anatomy of the distal transverse sinus.  Studies have shown that 
after normalization of the CSF pressure, resolution of the dural sinus narrowing occurs.  
5. Endocrinological and metabolic factors 
The association between PTC, female gender and obesity suggests an endocrine basis for 
this disorder.  Reports of PTC occurring in corticosteroid deficient states such as Addison's 
disease, and following the removal of an ACTH secreting pituitary adenoma (Ross & 
Wilson, 1988), implies abnormalities in the adrenal pituitary axis. Furthermore, 
corticosteroids effectively treat PTC and corticosteroid withdrawal is associated with PTC 
(Yasargil et al., 1990). However, Soelberg Sørensen et al. (1986) found no consistent 
abnormality in pituitary, gonadal, thyroid or adrenal function.  Multiple studies have 
documented the clear association between PTC and polycystic ovaries. In one study 
conducted by Glueck et al. (2003), 15 women out of 38 PTC patients were found to have 
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PCOS; 14 were obese, with a body-mass index (BMI) >30 kg/m2 and 10 were extremely 
obese (BMI > or = 40). 
6. Excess CSF production 
Quincke (1893) was the first to describe excess CSF production. The rate of CSF production 
can be measured through invasive procedures (Walker, 2001). Donaldson found an 
increased CSF rate, while other studies failed to demonstrate CSF hypersecretion in PTC 
patients ( Binder et al., 2004; Walker, 2001).  A noninvasive technique (MRI) to measure CSF 
production by recording the flow through the cerebral aqueduct produced highly variable 
results, which did not support the theory of CSF overproduction in PTC patients (Gideon et 
al., 1994). In an attempt to rule out this theory, experimental infusion of artificial CSF was 
injected into the lateral ventricles of dogs which led to ventricular enlargement, not a PTC- 
like syndrome (Greitz et al., 1992; Walker, 2001). 
7. CSF outflow reduction 
This theory, supported by most studies, proposes the pathogenesis of CSF outflow 
obstruction into the venous system, although existing reports are still controversial. Studies 
have shown that PTC is associated with CSF outflow impairment (Calabrese et al., 1978; 
Cameron, 1933; Malm et al., 1992; Martins, 1974) and no histological evidence of arachnoid 
villi granulation dysfunction. Controversy exists as to whether impairment of CSF outflow 
at the arachnoid granulation level may be pathophysiological. In infancy, agenesis, 
deficiency, or dyslasia of the arachnoid villi and granulations result in hydrocephalus, not 
PTC (Gilles & Davidson, 1971).  
Studies have demonstrated that in cases of elevated intracranial pressure attributed to high 
protein concentration in the CSF, (spinal tumor, Guillian-Barre syndrome), some patients 
develop hydrocephalus while others develop a PTC- like syndrome (Feldmann et al., 1986; 
Raichle et al., 1978; Ridsdale & Moseley, 1978; Ropper & Marmarou, 1984). It has been 
suggested that a high concentration of protein in CSF, may lead directly to impairment of 
CSF outflow. 
8. Chronic inflammation  
Recent reviews by Binder et al (2004) suggest that increased levels of cytokines and leptins 
(an adipocyte derivative hormone that circulates in the plasma at levels in proportion to 
body fat) in the CSF, may contribute to chronic inflammation and pathogenesis of 
intracranial hypertension in PTC patients. 
Hypercoagulable states, devoid of obvious dural sinus thrombosis, have been reported 
associated with and in some cases used to explain PTC's mechanism. Kesler reported on 
several individuals found to have antiphospholipid antibodies and hyperfibrinogenemia 
related to thrombosis (Kesler et al. 2000; Kesler et al., 2010). 
9. Drug associated 
Numerous published reports and studies have described the correlation between certain 
drugs and vitamins and the development of increased intracranial pressure. These include 
antibiotics such as tetracycline or minocycline (Giles & Soble, 1971), fluoroquinolones 
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(Winrow & Supramaniam, 1990), naladixicacids (Cohen, 1973), sulfamethozaxole (Ch’ien, 
1976) and hormonal treatments such as oral contraceptives, growth hormones, progesterone 
(Hamed et al., 1989; Rogers et al., 1999; Walsh et al., 1965), corticosteroid withdrawal 
(Neville & Wilson,1970), lithium (Saul et al, 1985) and  vitamin A use and its derivatives 
(Morrice et al., 1960, Spector & Carlisle, 1984; Visani, 1996) in doses exceeding 50,000 UI in 
adults and over 20,000 UI in children. 
10. Systemic conditions 
In the literature, various systemic diseases have been found to be associated with PTC, the 
most common being uremia (Campos & Olitsky, 1995) Toxic conditions, hypervitaminosis A 
tetracycline therapy, lithium,prolonged steroid therpy, Steroid withdrawal,. Other diseases 
include anemia (Capriles, et al. 1963), dysthyroidism (Campos & Olitsky, 1995; Huseman & 
Torkelson, 1984), Addison's disease (Condulis et al., 1997) cerebral sinus thrombosis, and 
sleep apnea. . 
11. Ancillary tests 
11.1 Neuroimaging 
The rationale for neuroimaging studies in PTC patients is twofold: prior to obtaining the 
cerebrospinal fluid, a brain imaging study is required to exclude any condition that would 
put the patient at risk of herniation, such as a tumor and to assure no secondary cause of 
increased ICP. The recommended study type has been modified together with the advance 
in neuroimaging technology. A CT scan is generally adequate as to ensure that the patient is 
not at risk when undergoing a lumbar puncture. The resolution is insufficient to exclude 
posterior fossa abnormalities, isodense lesions gliomatosis cerebri or venous sinus 
thrombosis. As either neuroimaging is acceptable, MRI of the brain with gadolinium is 
preferred over CT scanning with contrast. 
11.2 MRI  
Brain MRI is typically normal in the PTC patient, with a ventricular size normal for the 
patient’s age. An asymptomatic empty sella is a well known neuroimaging finding in 
patients with increased intracranial pressure and may be present in over 50% of cases 
(Silbergleit et al., 1989). The empty sella (Figure 2) is attributed to longstanding effects of 
pulsatile CSF under high pressure, leading to downward herniation of an arachnocele 
through a defect in the diaphragma sella (George, 1989). The incidence of empty sella 
ranged from 10% when plain radiographs of the skull were analyzed (Sorenson et al., 1989) 
to 94% when third-generation CT scans were analyzed (Gibby et al., 1993). 
Over the past few decades, other radiographic evidence of increased ICP in PTC patients has 
been detected using various neuroimaging techniques. Flattening of the posterior sclera is 
the most sensitive sign of elevated intracranial pressure, and was observed in 80% of 
patients with pseudotumor cerebri in Brodsky's study (Brodsky & Vaphiades, 1988). The 
flattening indicated transmission of elevated perioptic CSF pressure to the compressible 
posterior sclera. Jacobson (1995) found similar findings of bilateral posterior scleral 
flattening and distension of the perioptic subarachnoid space on MR imaging (Figure 3)in a 
patient with elevated intracranial pressure and unilateral papilledema. Furthermore, he 
emphasized that the constellation of acquired hyperopia and choroidal folds may indicate 
www.intechopen.com
 
Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) an Update 
 
381 
the presence of pseudotumor cerebri in rare patients whose distal optic nerves are 
structurally resistant to developing papilledema. 
A study by Jinkins et al (1996) found intraocular protrusion of the swollen optic disc in 10 
out of 15 patients with pseudotumor cerebri while examining the prelaminar optic nerves 
via MRI.  The optic disc appeared hypointense to vitreous on T2-weighted images. 
Upon administration of intravenous gadolinium, enhancement on T1 and T2 was produced 
in areas where the blood-brain barrier was absent or disrupted.  Intraocular enhancement of 
the swollen disc was found in 50% of MR images of patients with PTC resulting from diffuse 
prelaminar capillary leakage secondary to severe venous congestion. Distension of the 
perioptic subarachnoid space was present in 45% of patients with pseudotumor cerebri. A 
finding of intraocular protrusion of the prelaminar optic nerve can be visualized well on CT 
scanning (Lam et al., 1997; Jinkins et al., 1996), however, on MRI, no signal differential 
between the swollen optic disc and the vitreous cavity was observed (Connolly et al., 1992; 
Foley & Posner, 1975; 1989; Gass et al., 1996; Gideon et al., 1995; Mashima et al., 1996; 
Silbergleit et al.). 
 
 
Fig. 2. MRI image demonstrating an empty sella in a 26 year old PTC patient 
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Brodsky (1998) observed vertical tortuosity of the optic nerves in 8 out of 20 (40%) patients 
with pseudotumor cerebri compared to only one control subject. Since some tortuosity may 
exist in normal subjects, the ability of axial MR imaging to display relatively minor degrees 
of horizontal tortuosity, makes it a relatively nonspecific finding. Furthermore, vertical 
tortuosity of the orbital optic nerve is often accompanied by a “smear sign” on T1-weighted 
images where the midportion of the optic nerve is displaced from the field of view, causing 
it to appear obscured by a “smear” of orbital fat. The optic nerve tortuosity or kinking in 
patients with elevated intracranial pressure is attributable to the distal fixation of the optic 
nerves by the globes tethered to the orbits by their rectus muscles and check ligaments. 
Every patient suspected of PTC must routinely undergo an MRV or CTV examination. Both 
exams are equally reliable in identifying sinus vein thrombosis and therefore the decision of 
which examination to perform is entirely up to the expertise of the neurologist at the 
medical center. 
 
 
Fig. 3. Coronal T2 MRI image, demonstrating excess of CSF surrounding the optic nerves 
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11.3 MRV 
PTC is consistently associated with venous outflow disturbances. Sinus venous stenosis are 
found on MR venography in the large majority of PTC patients and may have various 
conformations, ranging from functional smooth narrowing of sinus segments associated or 
not associated with definite flow gaps, to segmental hypoplasia or aplasia of one or more 
central venous collectors. Stenosis is currently believed to be a consequence of primary 
altered cerebrospinal fluid (CSF) pressure since it may normalize after CSF subtraction with 
lumbar puncture or shunting procedures (De Simone et al., 2010). 
At present, the pathophysiologic mechanism of the elevated intracranial pressure in PTC 
remains unknown. Evidence suggests that perturbed venous efflux from the head may play 
a role in the etiology of the disease. Many studies suggest that elevated intracranial venous 
pressure, an underlying component of PTC, is the result of intracranial venous hypertension 
due to raised central venous pressure or disturbances of transverse sinuses (TSs) outflow 
(Brodsky et al., 1998;  Friedman & Jacobson, 2002; Gass et al., 1996; Jacobson et al., 1990). 
Occasionally, the clinical picture of PTC is the only clue to the presence of cerebral venous 
thrombosis, which may be a potentially devastating condition. Thus, every patient 
diagnosed with PTC must undergo an MRV or CTV to rule out this condition. 
MRV is a noninvasive technique effective in visualizing cerebral venous sinuses (Mattle et 
al., 1991). Different MRV sequences offer the capability of investigating cerebral sinovenous 
outflow from multiple orientations such as two-dimensional time-offlight (2D-TOF) and 
three-dimensional phase-contrast (3D-PC) techniques. However, all these techniques have 
limitations and pitfalls (Ayanzen et al., 2000; Pipe, 2001).  
A prospective study by Farb et al. (2003) suggested an auto-triggered elliptic-centric-ordered 
three-dimensional gadolinium enhanced MR venography (ATECO MRV) to evaluate the 
cerebral venous outflow of patients with PTC in combination with a novel scoring system. 
They found substantial bilateral sinovenous stenoses in 27 out of 29 (93%) patients with PTC 
compared to only 4 out of 59 in the controls and concluded that using ATECO MRV and a 
novel grading system for quantifying sinovenous stenoses, the authors could identify PTC 
patients with a sensitivity and specificity of 93%. 
Higgins et al. (Higgins et al., 2004) described a distinctive pattern in the signal phase of 
contrast MRV in PTC patients. They found "signal gaps" in both lateral sinuses of PTC 
patients, unobserved in their control group. These "signal gaps" may indicate that flow 
velocities over that specific segment are outside the range prescribed in their study.  
This finding does not necessarily mean that a thrombus is present nor does it inevitably 
indicate that abnormal arachnoid granulations might have caused a local alteration of blood 
flow. However, it does raise the possibility of stenosis or occlusion. 
Higgins et al. (2002) reported the first patient with refractory PTC and transverse sinus 
stenosis treated with a stent.  Direct cerebral venography and manometry confirmed the 
presence of stenoses with raised pressure, proximal to the obstructions. Dilation of one of 
the sinuses with a stent reduced the pressure gradient with dramatic symptomatic 
improvement. 
Current evidence (Higgins et al., 2003; Metellus et al.; Ogungbo et al., 2003; 2005; Rajpal et 
al., 2005) suggests that selected patients with PTC may benefit from a transverse sinus (TS) 
stent. Restoring the patency of stenotic TSs with a stent in patients with refractory IIH 
resulted in a resolution or significant improvement in headache and papilledema. 
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11.4 CT and CTV  
Neuroimaging utilizing CT offers rapid image acquisition, wide availability and excellent 
spatial resolution.  The speed and ability of a CT to detect acute blood or bone abnormality 
makes this technique very valuable in traumatic cases. 
Due to the rise in availability of MRI and MRV during the past few decades, and their 
known advantages over CT scans, the use of a CT as a neuroimaging tool in diagnosing PTC 
patients has lessened over the years.  Current studies in the literature are focusing mainly on 
MRI and MRV findings in neuroimaging rather the CT.  
Almost 25 years ago, Jinkins (1987) first reported on the reversal of the optic nerve head in a 
variety of conditions associated with increased intracranial pressure, including 
pseudotumor cerebri. Enlarged optic nerve sheaths have also been observed in patients with 
pseudotumor cerebri. Weisberg (1985) found that 2/28 patients had enlarged optic nerves, 
although no measurements were provided and no control values were available. Six out of 
28 patients were described as having a “small-sized ventricular system.” These 
examinations were performed on a second-generation CT scanner, without controls and in a 
non-blinded manner. 
Almost two decades ago, Gibby et al. (1993) published a paper on CT findings in their PTC 
patients. The purpose of their study was to evaluate and compare orbital and cerebral CT 
findings in PTC patients with those of age and sex matched controls. Ventricular size in both 
groups was evaluated.  Their findings matched Huckman et al’s (1976) who found no 
differences between ventricular sizes of patients with pseudotumor cerebri and those of a 
control population. 
Empty sellae have been associated with many conditions causing increased intracranial 
pressure. Gibby et al. in 1993 observed empty sellae in 5% of 788 autopsies (Kesler et al., 
2001). In the PTC group, 16 (94%) out of 17 patients had at least partial empty sella. The 
degree of empty sellae was significantly greater than in the controls. The high prevalence 
noted in patients with pseudotumor cerebri is compatible with their chronic elevated 
intracranial pressure, which averaged 370 mm H2O. CT angiography uses a high speed 
spiral scanner, providing excellent vessel resolution with a 3-dimensional capability, 
comparable to an MRA. The technique requires iodinated dye and ionizing radiation and 
takes approximately 15 minutes. Sensitivities in detecting aneurysms >3mm or stenosis 
>70% are approximately 95%. Some centers prefer the use of a CTA over an MRA in 
identifying cerebral aneurysms, including those causing ocular motor cranial nerve palsies. 
11.5 Visual field perimetry 
Visual field testing by either automated Humphrey static or manual Goldmann perimetry 
reveals enlargement of the physiological blind spot in virtually all patients with PTC. Other 
common visual field defects include inferonasal loss and generalized constriction of the 
fields. Central defects, arcuate and altitudinal defects may occur but are highly unlikely.  
However, if found, a search is warranted for another cause, unless a large serous retinal 
detachment from a high-grade optic edema, spreading to the macula area, is found. 
Almost all PTC patients suffer from some type of visual field loss over time. In prospective 
(Wall & George, 1987; Wall & George, 1991) studies of patients with PTC, visual field loss in 
at least 1 eye (other than an enlargement of the blind spot due to the edematous optic nerve) 
was found in 96% of patients using a Goldmann perimetry, a disease specific strategy and in 
92% with automated perimetry. Approximately one third of this visual field loss was mild 
and was usually not noticed by the patient (Wall & George, 1991). 
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Wall et al’s study (1991) showed that with treatment, about 50% of patients experience a 
significant visual field improvement. They further demonstrated that the only subgroup of 
patients who had a worsening of their visual fields were those with a recent weight gain. 
This was the only factor significantly associated with a decline in vision. 
11.6 Ultrasound of optic nerve  
Ultrasound has been used to identify intracranial hypertension by measuring the optic 
nerve sheath diameter. The modality is extremely safe and does not have any 
contraindications for use, except for ocular globe injuries (Munk et al., 1991). In most 
modern medical facilities, multipurpose ultrasound units with high-frequency transducers 
(>7.5 MHz) provide high lateral and axial precision (Berges et al., 2006). 
Hayreh (1964) in an experimental study of monkeys and humans showed that the 
subarachnoid spaces surrounding the optic nerve is in continuity with the intracranial 
cavity, and therefore changes in cerebrospinal fluid pressure may be transmitted along the 
optic nerve sheath (Hayreh, 1964). The retrobulbar enlarged optic nerve sheath can therefore 
inflate as a consequence of raised pressure in the cerebrospinal fluid. 
It has been confirmed that the optic nerve sheath diameter (ONSD) increases in patients 
with intracranial hypertension (Blaivas et al., 2005; Geeraerts et al., 2007; Girisgin et al., 2007; 
Karakitsos et al., 2006; Malayeri et al., 2005; Munk et al., 1991; Salgarello et al., 1996; Stone, 
2009). ONSD alterations are correlated with head CT scan results in brain injured adults 
(Karakitsos et al., 2006) as well as with the invasive and noninvasive measurements of the 
ICP (Soldatos et al., 2008). 
During US evaluation, it is important to perform a 30 test to evaluate excess of fluids within 
the arachnoid sheaths of the optic nerve. The patient is asked to turn approximately 30 
toward the probe placed temporally on the globe. The measurements in abduction are 
compared with the measurements at the primary position. If fluid excess is present, the 
diameter at 30 will be smaller than that found in the primary position. 
11.7 Optical coherence tomography (OCT) 
OCT is a non-invasive imaging technique yielding high-resolution, cross-sectional images of 
the retina. More importantly, it is a valuable modality used to identify the status of the 
retinal nerve fiber layer as well as to measure macular thickness. The technique is 
principally based on measuring the time required for light to reflect from the tissue to an 
external detector (i.e. “echo time delay”). Duration of time and intensity of the backscattered 
light corresponds directly to the depth and density of the tissue being imaged. OCT 
produces in vivo cross-sections which can be serially acquired (in thin sections) in order to 
obtain tomographic images (Schuman et al., 2004). 
The principles underlying OCT are similar to those of ultrasound imaging, except that light 
is utilized instead of sound. The axial resolution of OCT images is at least 1-2 orders of 
magnitude greater than those of ultrasound. OCT images of the retina provide a spatial 
resolution as low as 3-5 microns (Huang et al., 1991; Schuman et al., 2004). 
Currently, two main types of OCT are utilized in practice: the time-domain, employing 
low-coherence interferometry for imaging tissue structures, and the spectral-domain OCT. 
Spectral-domain imaging provides faster and more spatially detailed images than the 
time-domain method. In addition, spectral domain OCT allows for imaging at a speed of 
18,000 to approximately 40,000 A-scans per second, fast enough to eliminate artifacts from 
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eye movements. It also provides a greater resolution of the retina with subsequent better 
visualization of the laminar structure and clarification of details at the cellular level 
within the nuclear layers (Choi et al., 2008). Several reports have also described 
particularly good reproducibility of RNFL and optic disc measurements with the newer 
spectral-domain technique (Gonzalez-Garcia, et al., 2009; Leung et al., 2009; Menke et al., 
2008). 
Computer-aided image processing algorithms have been developed to estimate NFL 
thickness from circumpapillary OCT images acquired in cylindrical sections surrounding 
the optic disc. A circumpapillary scan pattern of a typically ¾ mm diameter is used, because 
it effectively intercepts all nerve fibers originating from the optic disc, thus enabling a 
quantitative measurement of the circumferential variations in NFL thickness around the 
optic disc as well as  visualization of the nerve fiber bundles. 
Studies have demonstrated the effectiveness of time-domain OCT in providing a 
quantitative measure of the severity of disease, response to treatment and follow up 
monitoring of patients with PTC (Ophir et al., 2005; Rebolleda & Munoz-Negrete, 2009). 
RNFL thickness decreased correspondingly, with the improvement recorded at the patients' 
clinical evaluation. The study outcomes provided a basis for using OCT to predict which 
patients would ultimately fare better in terms of visual functional status (Rebolleda & 
Munoz-Negrete, 2009). 
Precise measurements obtained with OCT allow the physician to more accurately evaluate 
the treatment effect than the subjective interpretation of the funduscopic appearance of the 
optic nerve heads. Recently, studies have emphasized the importance of viewing the macula 
in these patients. Hoye et al. (2001) evaluated the detection and monitoring of sub-retinal 
fluids extending from the optic nerve head to the macula in patients with papilledema. The 
authors found that the fluids accounted for the reduced visual acuity in 7 out of 55 patients, 
and when the volume of sub-retinal fluids decreased, an improvement in the visual acuity 
function was noted. 
Future OCT assessment of papilledema will be evaluating the total optic nerve head disc 
volume and maximal optic nerve head height, as these measures potentially correlate with 
the response to medication and ultimate visual outcome. At present, clinical evaluation of 
the optic nerve head volume, better reflects the overall degree of optic nerve head edema 
rather than the thickness of the RNFL alone, since volume measurement incorporates the 
volume of both the total optic nerve height and the sub-retinal hypo reflective space. 
(Johnson et al., 2009).  
11.8 Fluorescein angiography 
Fluorescein angiography was initially developed as a tool for studying retinal vascular flow 
characteristics. Extensive use of fluorescein angiography and technique refinement has 
allowed the clinician and researcher to better understand the pathophysiologic and 
histopathologic changes of fundus disease in vivo. Fluorescein angiography may aid the 
clinician in accurately diagnosing papilledema by the appreciation of leakage or late 
hyperfluorescence surrounding the optic disc. Blocked hypofluorescence may be noted at 
the optic nerve head during papilledema as a result of bleeding, which is present at the level 
of the neurosensory retina, blocking the fluorescence from the underlying choroid (Rabb et 
al., 1978).  
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12. Management   
There are nonsurgical and surgical approaches to PTC, decisions based on symptomatology 
and visual function status. If a headache is controlled by common analgesics and no optic 
nerve dysfunction is observed, therapy may not be required. Asymptomatic patients with 
preserved vision and minimal papilledema warrant only frequent follow-ups as well as 
monitoring disc swelling and visual function, including visual fields (Nonne, 1904).  
12.1 Medical (nonsurgical) approach 
Acetazolamide, a carbonic anhydrase inhibitor that decreases CSF production by the 
choroid plexus, is generally accepted as first-line medication, although its efficacy has not 
been proven in prospective trials. Based on our experience, a starting regimen of 
acetazolamide 500 mg, orally two or three times per day, is preferred. The dose can be 
increased to a total of 3 grams per day, if necessary. Major side effects include diuresis, loss 
of appetite, abnormal taste (metallic taste with carbonated beverages) paresthesias of the 
lips, fingers and toes, malaise, renal colic and metabolic acidosis (Corbett et al., 1982). Most 
of these side effects resolve with potassium and magnesium-rich dietary supplements such 
as bananas and oranges. Severe adverse effects experienced with acetazolamide treatment 
include acute tubular necrosis, hepatic dysfunction, and aplastic anemia. 
Teratogenic effects in animals such as limb malformations and cortical dysgenesis have been 
reported (Quincke, 1893). Although sacrococcygeal teratoma in neonates (Tibussek et al., 
2010) have been documented in the past, there is little clinical or experimental evidence to 
support any adverse effect of the drug on pregnancy outcome in humans (Spence  et al., 
1980). If acetazolamide fails, topiramate, an anti-epileptic drug, may be used. Its therapeutic 
effects are due to its carbonic anhydrase inhibitory properties. The drug is particularly 
useful as a prophylaxis for headaches, appetite suppression and weight loss (Nonne, 1904). 
The dose should be built up slowly over weeks (25 mg/week) in order to reduce the risk of 
cognitive side effects. It is of utmost importance to regularly check the intraocular pressure 
(IOP) of patients undergoing this treatment, as elevation of IOP is a known side effect of 
topamax. 
Short-term oral corticosteroids may be considered as a treatment option in patients 
presenting with severe headaches, marked papilledema, and very high intracranial 
pressure. High doses of intravenous corticosteroid treatment may occasionally be 
administered when there is rapidly progressive vision loss or while the patient awaits 
surgery (Mathews et al., 2003). 
Treatment medication is usually given over a long period of time. ICP-lowering agents may 
be tapered and eventually discontinued when the patient’s visual status and optic nerve 
appearance have improved and stabilized. Patients should be periodically monitored post 
treatment, since recurrences are common. If symptoms reoccur, reinstitution of medications 
is usually indicated (Friedman & Jacobson, 2004).  
Weight loss is a crucial part of the treatment program, as even moderately obese patients 
may significantly benefit from a sensible diet and exercise program (Mathews et al., 2003).  
Medications known as associated risk factors for pseudotumor syndromes, such as vitamin 
A, vitamin A derivatives, and tetracycline should be discontinued if possible. 
12.2 Lumbar puncture 
In the past, repeated lumbar punctures were an acceptable treatment modality due to 
improvement of symptoms after the procedure. Nowadays, this type of treatment approach 
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is less acceptable. Currently, lumbar puncture may be indicated in pregnant women or 
when the clinical picture points to rapidly declining vision, thus temporarily lowering the 
CSF pressure while planning a more aggressive treatment (Friedman & Jacobson, 2004). In 
the past serial lumbar punctures (e.g., twice weekly) have been proposed as an alternative to 
surgery for patients with papilledema, when the disease cannot be controlled medically. 
Complications of the procedure such as infection, tonsillar herniation, radiculopathy, and 
arachnoiditis are rare. 
12.3 Surgical approach 
The most frequent and accepted indication for surgery is a progressive loss of vision despite 
maximal medical therapy. Surgery should be carried out as soon as a visual field defect 
worsens or remains unimproved despite maximal treatment. Medical treatment fails in 
approximately 18% to 22% of patients with PTC (Burgett et al., 1997; Corbett & Thompson, 
1989; Lorberboym et al., 2001; Lueck & McIlwaine, 2002; Pearson et al., 1991). According to 
Friedman et al (2004), ophthalmological indications for surgical intervention are severe or 
rapid visual loss at onset (“malignant IIH”), severe papilledema causing macular edema or 
exudates without improvement while undergoing medical treatment. Even if there is no 
consensus among the specialists (Friedman & Jacobson, 2004), surgery should be considered 
in the management of intractable headaches (Binder et al., 2004; Mathews et al., 2003). 
Surgical treatment options include optic nerve sheath fenestration (ONSF) and CSF 
diversion procedures. A CSF shunt reduces intracranial hypertension, whereas ONSF 
focuses on protecting the vulnerable optic nerve head. 
12.4 Optic nerve sheath decompression (ONSD) 
The mechanism by which ONSD works has not been clarified, but several theories have 
been suggested. Keltner (1988) suggests that it may provide a filtering effect, with a 
subsequent decrease in the local CSF pressure, improvement of the peripapillary circulation 
(Keltner, 1988), or produce a generalized decrease in ICP. According to another hypothesis, 
the scarring of the arachnoid by the procedure itself may protect the nerve head from 
elevated CSF pressure (Friedman & Jacobson, 2004). Technically, ONSD is performed by 
uncovering the optic nerve sheath through a lateral orbitotomy or through a medial 
approach via a transconjunctival incision. Multiple linear incisions are made or a window is 
cut into the anterior dural that covers the optic nerve sheath, creating a CSF drainage outlet 
(Mathews et al., 2003). 
The overall complication rate of ONSD ranges from 4.8% to 45% (151,165,166,167,168), the 
most common being extraocular motility problems due to lateral rectus palsy which is 
usually transient, and papillary abnormalities. Other complications may include long-term 
and transient blindness due to ischemic injury to the optic nerve, orbital hemorrhage, visual 
field defects and globe perforation (Friedman & Jacobson, 2004). In the majority of patients, 
post-ONSD vision stabilizes or improves in the long-term, but as many as 32% of operated 
eyes may experience deterioration following initially successful surgery (McHenry & Spoor, 
1993). A reoperation can be performed, but based on clinical experience, a shunting 
procedure is recommended in these cases.  
12.5 Lumbar peritoneal shunt (L-P shunt) 
Although an L-P shunt is considered an effective procedure, failure and low pressure-
related headaches are common. Shunts may be efficiently placed in the lumbar cistern, 
www.intechopen.com
 
Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) an Update 
 
389 
cisterna magna, or the ventricles. The lumboperitoneal (L-P) technique has traditionally 
been the method of choice in PTC. 
A review of the literature Binder et al (2004) found that the efficacy of L-P shunting is 
maintained as long as the shunt remains patent. The failure rate for LP shunts range from 
38% to 64% (Burgett et al., 1997; Gupta et al., 2007; Johnston et al., 1988). Major causes 
include catheter obstruction, over-shunting (low pressure headaches), catheter migration, 
and lumbar radiculopathy. 
12.6 Ventriculoperitoneal (V-P) shunts 
A V-P shunt is difficult to perform due to relatively small or normal ventricle size.  
However, this technique is becoming increasingly popular in treating PTC (Binder et al., 
2004; Maher et al., 2001; Tulipan et al., 1998).  
In the long-term, V-P shunts offer advantages compared to the L-P shunt method, especially 
with regard to shunt revision (Kang, 2000; Maher et al., 2001). The procedure does not 
present the risk of inducing a Chiari I malformation, and may be less likely to over-drain. 
A wider range of shunts are available for the V-P route. Usually, PTC patients benefit from 
relatively high-pressure valves (possibly with an antisiphon system to limit over-drainage), 
which are able to retain sufficient intracranial CSF to compensate the changing intracranial 
volume conditions and limit the collapse of the ventricular system around the shunt 
catheter. Flow-regulated valves have also been proposed (Garton, 2004). 
12.7 Subtemporal decompression 
The first neurosurgical technique to treat PTC patients, by a subtemporal decompression, 
was performed in 1937 (Dandy, 1937). Dandy performed a unilateral subtemporal 
craniectomy with excellent initial results in alleviating headaches and preventing visual loss. 
The long-term efficacy of the procedure was uncertain, since a high rate of morbidity and 
complications were reported, including seizures, infections, focal brain damage, cosmetic 
disfigurement, intracranial hematomas, and further visual deterioration (Binder et al., 2004). 
After introducing stenting procedures for treating IIH, this procedure became obsolete; 
nonetheless, subtemporal decompression is still an option, when other surgical methods 
have failed.    
12.8 Endovascular stenting 
It is highly controversial whether venous sinus narrowing is the cause or the result of 
elevated intracranial pressure. Based on the frequent findings in MRI venography of 
narrowed transverse sinuses, endovascular stenting of the venous sinuses has been recently 
advocated by some authors (Higgins et al., 2002; Higgins et al., 2003; Metellus et al., 2005; 
Metellus et al., 2007; Donnet et al., 2008; Paquet et al., 2008).  
Higgins et al (2002) was the first to report on a 30 year old patient with refractory PTC, 
papilledema and bilateral TS stenosis found on an MR venogram, that was successfully 
treated with dilation of 1 of the sinuses with a stent, thus reducing the pressure gradient 
with dramatic symptomatic improvement. 
As of today, only about 40 patients with PTC, treated with sinovenous stent placement, have 
been reported in the literature. Most were women aged 15-65, symptomatic with PTC for 2 
weeks to 15 years. After stent placement, 33 out of the 40 (82.5%), reported a significant 
improvement in their headaches. Papilledema improved or resolved in 30 out of 33 (91%) 
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patients who presented with active papilledema. Although the promising initial results of 
long term efficiency of the procedure still needs to be proven, further investigation is still 
warranted to prove the procedure as a useful treatment technique. 
12.9 Pregnancy and PTC  
Current reports suggest that pregnant patients with PTC can be safely managed similarly to 
nonpregnant patients with PTC.  No increase in the rate of spontaneous abortion or fetal 
wastage has been reported. A therapeutic abortion to limit the progression of the disease is 
not indicated. (Tang et al., 2004).  
Acetazolamide had previously been considered as the preferred therapy after 20 weeks of 
gestation, since sacrococcygeal teratoma was reported with earlier use (Digre et al., 1984). A 
recent report of 12 women treated with acetazolamide for PTC during pregnancy, showed 
no adverse pregnancy outcomes in terms of fetal loss or congenital malformation. 
Acetazolamide at high doses may produce birth defects in animals, but there is little clinical 
or experimental evidence to support any adverse effect on pregnancy outcome in humans. If 
the clinical situation mandates acetazolamide use in PTC, the drug can be offered after 
appropriate informed consent (Lee et al., 20050).  Management of labor and indications for 
cesarean delivery for a parturient with PTC are controversial. Regular labor may be allowed 
with a cesarean delivery reserved for obstetric indications. 
13. Natural history and visual prognosis 
The natural history of PTC is unknown. In some cases, it is a self-limited condition, while in 
others ICP may remain elevated for many years even if systemic and visual symptoms 
resolve. In some patients, the process may last from months to years. Individuals with mild 
to moderate visual loss tend to recover vision following medical therapy. Papilledema 
usually resolves after a few weeks or months, but many patients are left with some residual 
disc elevation, especially nasally. Severe visual impairment may be a serious and permanent 
complication of PTC. PTC produces significant visual impairment in approximately 25% of 
patients. The risk of visual loss in the pediatric PTC population is similar to that of adults 
(Corbett & Thompson, 1989). Recurrent symptoms have been reported in 8 to 37% of 
patients, years after being diagnosed (Corbett & Thompson, 1989). Visual deterioration in 
PTC patients is usually gradual, but in cases of fulminant papilledema, blindness may 
appear rather quickly. In Corbett et al’s (1989)  follow up study of 5 - 41 years after the initial 
diagnosis of 57 patients, revealed severe visual impairment in 14 patients (24.6%). In Kesler 
et al's experience (2004), recurrence was frequently associated with weight gain. The long-
term prognosis and visual outcome of 54 patients with IIH was observed over a period of 6.2 
years. The results showed that recurrences occurred in almost 40% of the cases. None of 
these exacerbations occurred during the first 10 months, and none occurred while the 
patients continued treatment.  
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